Recent BioUtah News & Events

Renalytix announced the successful completion of $30.0 million financing package

CURTIS, CRAIG INTRODUCE BILL TO IMPROVE ACCESS TO GENERIC TREATMENTS

Taylor Randall inaugurated as President of University of Utah

Funding to Enable Continued Development of Precision Metagenomics Advancing Platform

Donates Monetary Winnings to Biohive’s Non Profit Work to Bring STEM Education to Underrepresented Communities

SINTX Technologies announced a Phase 1 grant of $300k awarded by the National Institutes of Health (NIH) to develop, design and characterize 3D printed implants for craniomaxillofacial (CMF) applications using a composite of silicon nitride and polyetherketoneketone (SN-PEKK).

Results show significant survival benefit in participants who entered open-label extension of study of CNM-Au8®, a gold nanocrystal suspension, compared to validated ENCALS prediction mode

On Monday, March 28, President Biden announced his budget for FY23, a $5.8 trillion proposal that reflects the administration’s funding priorities, many of which were drawn from the initial Build Back Better package.  Congress is not required to adopt any or all of the president’s budget. However, each year, the president’s budget proposal serves as […]

Fresenius Medical Care participates in three-way merger to create premier value-based kidney care provider in the U.S.

The Biden Administration’s Investment in Pandemic Preparedness and Biodefense in the FY 2023 President’s Budget

Diversified Medical Healthcare Acquires Utah Lab, Dynasty Medical Laboratory Services

Renalytix Reaches Enrollment Milestone for Building KidneyIntelX as Premier Precision Medicine Platform for Kidney Disease and Diabetes

Confirmation of Appointment of Timothy Scannell to Renalytix Board of Directors

SALT LAKE CITY, March 30, 2022 /PRNewswire/ — PolarityTE, Inc. (Nasdaq: PTE) a biotechnology company developing regenerative tissue products and biomaterials, today provided a business update and reported financial results for the twelve-month period ended December 31, 2021. Recent Business and Financial Updates In the first quarter of 2022, PolarityTE received approval from the U.S. […]

The total capital represents the largest seed financing for life science startups in Utah’s history

Halia Therapeutics presented data today on its NLRP3 inhibitor program at today’s 10th Annual Neurodegenerative Drug Development Summit. 

Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2022

The FDA and representatives from the medical device industry have reached an agreement on proposed recommendations for MDUFA V. On March 22, FDA sent the commitment letter to Congress. Under the new agreement, the FDA would be authorized to collect at least $1.78 billion in user fees over five years. FDA could receive additional funding […]

Pfizer’s $6.7 billion bet on Arena Pharmaceuticals has delivered a phase 3 success.

Recursion reported business updates and financial results for its fourth quarter and fiscal year ending December 31, 2021.

FierceBiotech Special Report: The top 10 biotech IPOs of 2021

Achieved Record Full Year Revenue of $97.9 Million; Strength in Sales Momentum Provides Foundation to Achieve Solid FY’22

WTC UTAH HAS A RECORD $1M+ TO ADMINISTER TO UTAH SMALL BUSINESSES. Learn from World Trade Center Utah, Meridian Finance Group, and the U.S. Small Business Administration (SBA) about export programs through the Export-Import Bank of the United States (EXIM) and how State Trade Expansion Program (STEP) funds can be used for those programs as a new eligible expense.

Co-Diagnostics, Inc. Makes Strategic Additions to Scientific Advisory Board